Severe Combined Immunodeficiency (SCID)-the Irish Experience

Heather Burns^{1

2}, Abigail Collins^{3

4}, Paul Marsden^{3

4}, Terence J Flood⁵, Mary A Slatter⁵, Claire Booth^{6

7}, Jinhua Xu-Bayford⁶, Timothy Ronan Leahy^{8

9}

Affiliations

¹ National Newborn Bloodspot Screening Programme Governance Group , Dublin, Ireland. heathersan@gmail.com.
² Department of Public Health, Health Service Executive, Tullamore, Co Offaly, Ireland. heathersan@gmail.com.
³ National Newborn Bloodspot Screening Programme Governance Group , Dublin, Ireland.
⁴ Department of Public Health, Health Service Executive, Tullamore, Co Offaly, Ireland.
⁵ Department of Paediatric Haematopoietic Stem Cell Therapy and Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.
⁶ Department of Paediatric Immunology and Gene Therapy, Great Ormond Street Hospital, London WC1N 3JH, United Kingdom.
⁷ Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
⁸ Department of Paediatric Immunology and Infectious Diseases, Children's Health Ireland at Crumlin , Dublin, Ireland.
⁹ Department of Paediatrics, University of Dublin, Trinity College, Dublin, Ireland.

Heather Burns et al. J Clin Immunol. 2021 Nov.

. 2021 Nov;41(8):1950-1953.

doi: 10.1007/s10875-021-01106-3. Epub 2021 Aug 10.

Heather Burns^{1

2}, Abigail Collins^{3

4}, Paul Marsden^{3

4}, Terence J Flood⁵, Mary A Slatter⁵, Claire Booth^{6

7}, Jinhua Xu-Bayford⁶, Timothy Ronan Leahy^{8

9}

¹ National Newborn Bloodspot Screening Programme Governance Group , Dublin, Ireland. heathersan@gmail.com.
² Department of Public Health, Health Service Executive, Tullamore, Co Offaly, Ireland. heathersan@gmail.com.
³ National Newborn Bloodspot Screening Programme Governance Group , Dublin, Ireland.
⁴ Department of Public Health, Health Service Executive, Tullamore, Co Offaly, Ireland.
⁵ Department of Paediatric Haematopoietic Stem Cell Therapy and Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.
⁶ Department of Paediatric Immunology and Gene Therapy, Great Ormond Street Hospital, London WC1N 3JH, United Kingdom.
⁷ Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
⁸ Department of Paediatric Immunology and Infectious Diseases, Children's Health Ireland at Crumlin , Dublin, Ireland.
⁹ Department of Paediatrics, University of Dublin, Trinity College, Dublin, Ireland.

No abstract available

References

1. Rivers L, Gaspar HB. Severe combined immunodeficiency: recent developments and guidance on clinical management. Arch Dis Child. 2015;100(7):667–72. - DOI
1. Gaspar HB, Hammarström L, Mahlaoui N, Borte M, Borte S. The case for mandatory newborn screening for severe combined immunodeficiency (SCID). J Clin Immunol. 2014;34(4):393–7. - DOI
1. Adams SP, Wilson M, Harb E, et al. Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: segregation of genotypes with specific ethnicities. Clin Immunol. 2015;161(2):174–9. - DOI
1. Flinn AM, Flood T, Prendiville T, Gennery AR, Leahy TR. Adenosine deaminase deficient SCID with myocardial hypertrophy. J Clin Immunol. 2021.
1. Pai SY, Logan BR, Griffith LM, et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med. 2014;371(5):434–46. - DOI